Live music sessions for people with dementia in Pontypool
The initiative, funded by The National Lottery Community Fund's 'Awards for All' programme, aims to improve the emotional wellbeing of people with dementia.
The sessions, which are tailored for people aged 50 and over, will take place twice a month for the next two years.
Emma Wooten, development manager at Age Connects Torfaen, said: "The idea is to explore whether live music resonates with our service users.
"Some of them are nonverbal, but as soon as the music starts, their faces light up, they clap, tap along, or even start to sing.
"It brings back memories - maybe it is their wedding song or a tune from a family celebration.
"Music evokes strong emotions and can trigger joyful or meaningful memories."
The charity said that 76 per cent of residents reported feeling less isolated after participating in Music in Hospitals & Care live music, while 78 per cent of residents felt less stressed and anxious.
Ms Wooten added: "With something like Alexa or YouTube playing in the background, distractions are common, but with a live performance they are captivated.
"That is rare for someone with dementia, whose attention span is often short."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
a day ago
- Scottish Sun
Ozempic-like fat jabs are BETTER than common drug at reducing dementia risk, study finds
Plus, all the ways you can lower your dementia risk if you have type 2 diabetes WIN WIN Ozempic-like fat jabs are BETTER than common drug at reducing dementia risk, study finds Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, say scientists. While both medications demonstrate neuroprotective properties, no comparison has been made up until now. Sign up for Scottish Sun newsletter Sign up 1 GLP-1 receptor agonists have recently gained popularity as a weight loss medication Credit: Getty Metformin is generally the first-line medication for type 2 diabetes, while GLP-1 receptor agonists are often used as second-line or add-on therapy when metformin is not sufficient or tolerated. In recent times, GLP-1 receptor agonists have gained popularity as a weight loss medication due to their ability to suppress appetite and promote feelings of fullness. Previously published research indicated people with type 2 diabetes have a significantly increased risk of developing dementia, with some studies reporting a 70 per cent higher risk compared to those without diabetes. And both GLP-1 receptor agonists and metformin have been shown to protect the brains of people with type 2 diabetes. But in the largest study of its kind, published in BMJ Open Diabetes Research & Care, GLP-1 receptor agonists were found to trump metformin when it comes to dementia risk. Researchers analysed health records from the period 2004 to 2024 to track the development of dementia in patients with type 2 diabetes who were treated with either GLP-1 receptor agonists or metformin for at least six consecutive months. While there was no significant difference in vascular dementia risk between the two types of drug, GLP-1 receptor agonist use was associated with a significantly lower risk of developing dementia, overall. Specifically, taking GLP-1 receptor agonists was linked to a lower risk of developing Alzheimer's disease, and a 25 per cent lower risk of developing non-vascular dementias than metformin use. These positive effects were evident across all age groups, but with the strongest effect among the over 60s, women, and those of white ethnicity. Risk of death from any cause was also found to be lower - nearly 5 per cent of those treated with GLP-1 receptor agonists died compared with nearly 9 per cent of those treated with metformin. The 14 science-backed ways to prevent dementia 'Both medications demonstrate neuroprotective properties, such as reducing neuroinflammation and oxidative stress, improving insulin sensitivity, and enhancing cerebrovascular health, which likely contribute to their benefits in overall dementia,' explain the researchers. But unlike metformin, GLP-1 receptor agonists exert direct central nervous system effects by crossing the blood-brain barrier, they add. The researchers point out their tracking period, while sufficient for observing dementia outcomes, may not fully capture long-term cognitive effects, especially given the progressive nature of Alzheimer's disease. But they conclude: "Given the severe societal, familial , and economic burden of diabetes-related dementia, these findings raise important considerations about the tole of GLP-1 [receptor agonists] as first-line therapies in [type 2 diabetes] management. "While further long-term studies are warranted to validate these results, integrating GLP-1 [receptor agonists] as primary therapeutic agents may represent a paradigm shift in preventing the cognitive complications of diabetes.' All GLP-1 medicines are prescription only medicines, which means they can only be prescribed by a healthcare professional. GLP-1 medicines can also be purchased privately. If you want to get a GLP-1 medicine privately, a consultation with a healthcare professional must happen before the prescription can be issued, so the prescriber can carry out proper checks and make sure you are aware of the benefits and risks of taking the medicine. GLP-1 medicines should not be bought from unregulated sellers such as beauty salons or via social media, or from anywhere without a prior consultation with a healthcare professional. The Medicines & Healthcare products Regulatory Agency (MHRA) has had reports of people experiencing severe side effects from fake GLP-1 medicines.
The Sun
a day ago
- The Sun
Ozempic-like fat jabs are BETTER than common drug at reducing dementia risk, study finds
FAT jabs are better than widely prescribed metformin when it comes to curbing dementia risk in people with type 2 diabetes, say scientists. While both medications demonstrate neuroprotective properties, no comparison has been made up until now. 1 Metformin is generally the first-line medication for type 2 diabetes, while GLP-1 receptor agonists are often used as second-line or add-on therapy when metformin is not sufficient or tolerated. In recent times, GLP-1 receptor agonists have gained popularity as a weight loss medication due to their ability to suppress appetite and promote feelings of fullness. Previously published research indicated people with type 2 diabetes have a significantly increased risk of developing dementia, with some studies reporting a 70 per cent higher risk compared to those without diabetes. And both GLP-1 receptor agonists and metformin have been shown to protect the brains of people with type 2 diabetes. But in the largest study of its kind, published in BMJ Open Diabetes Research & Care, GLP-1 receptor agonists were found to trump metformin when it comes to dementia risk. Researchers analysed health records from the period 2004 to 2024 to track the development of dementia in patients with type 2 diabetes who were treated with either GLP-1 receptor agonists or metformin for at least six consecutive months. While there was no significant difference in vascular dementia risk between the two types of drug, GLP-1 receptor agonist use was associated with a significantly lower risk of developing dementia, overall. Specifically, taking GLP-1 receptor agonists was linked to a lower risk of developing Alzheimer's disease, and a 25 per cent lower risk of developing non-vascular dementias than metformin use. These positive effects were evident across all age groups, but with the strongest effect among the over 60s, women, and those of white ethnicity. Risk of death from any cause was also found to be lower - nearly 5 per cent of those treated with GLP-1 receptor agonists died compared with nearly 9 per cent of those treated with metformin. The 14 science-backed ways to prevent dementia 'Both medications demonstrate neuroprotective properties, such as reducing neuroinflammation and oxidative stress, improving insulin sensitivity, and enhancing cerebrovascular health, which likely contribute to their benefits in overall dementia,' explain the researchers. But unlike metformin, GLP-1 receptor agonists exert direct central nervous system effects by crossing the blood-brain barrier, they add. The researchers point out their tracking period, while sufficient for observing dementia outcomes, may not fully capture long-term cognitive effects, especially given the progressive nature of Alzheimer's disease. But they conclude: "Given the severe societal, familial , and economic burden of diabetes-related dementia, these findings raise important considerations about the tole of GLP-1 [receptor agonists] as first-line therapies in [type 2 diabetes] management. "While further long-term studies are warranted to validate these results, integrating GLP-1 [receptor agonists] as primary therapeutic agents may represent a paradigm shift in preventing the cognitive complications of diabetes.' All GLP-1 medicines are prescription only medicines, which means they can only be prescribed by a healthcare professional. GLP-1 medicines can also be purchased privately. If you want to get a GLP-1 medicine privately, a consultation with a healthcare professional must happen before the prescription can be issued, so the prescriber can carry out proper checks and make sure you are aware of the benefits and risks of taking the medicine. GLP-1 medicines should not be bought from unregulated sellers such as beauty salons or via social media, or from anywhere without a prior consultation with a healthcare professional. The Medicines & Healthcare products Regulatory Agency (MHRA) has had reports of people experiencing severe side effects from fake GLP-1 medicines. Ways to lower dementia risk with type 2 diabetes Manage blood sugar levels Strictly follow a diabetes management plan, as prescribed by a healthcare professional. This includes medication, diet and exercise. Regularly monitor blood sugar levels and manage insulin appropriately. Adopt a healthy lifestyle Follow a balanced diet in fruits, vegetables, whole grains, and lean protein, with limited saturated fat, sugar, and salt. Aim for at least 150 minutes of moderate-intensity exercise per week. Being overweight or obese can increase the risk of type 2 diabetes and other conditions linked to dementia. Weight management through diet and exercise can help mitigate these risks. Engage in activities that challenge your mind, such as puzzles, reading, learning new skills, or socialising. Address other risk factors High blood pressure and cholesterol can damage blood vessels, increasing the risk of both cardiovascular disease and dementia. Regular check-ups and appropriate treatment are essential. Excessive alcohol consumption can negatively impact brain health. Moderate drinking or abstaining from alcohol can be beneficial. Hearing loss can contribute to cognitive decline. Addressing hearing problems through hearing aids or other interventions can help maintain cognitive function. Seek professional guidance Regular medical check-ups are important for monitoring overall health and identifying and addressing potential risk factors early on. Work with your doctor, diabetes educator, or other healthcare professionals to develop a personalized plan for managing your diabetes and reducing your risk of dementia.
North Wales Chronicle
a day ago
- North Wales Chronicle
Healthy dad who smelt sugar ended up with brain cancer
After multiple examinations, the dad-of-four received the devastating news he had stage 4 IDH-wildtype glioblastoma, the most aggressive type of brain cancer. Since receiving his diagnosis, the 57-year-old, from Stoke-on-Trent, has received radiotherapy and chemotherapy, the only treatment options offered through the NHS for his type of cancer. The NHS identifies surgery, radiotherapy, chemotherapy and targeted medications as conventional treatments for glioblastoma. In 2005, you were on MySpace. Scrolling through your iPod. Watching the first videos on YouTube. 👾 That was also the last time glioblastoma treatment saw a major breakthrough. Soon, that changes. We're ushering in a new era of genomic testing designed just for glioblastoma —… Currently, his relatives are trying to raise £350,000 for a potentially life-extending treatment in Germany, with total costs expected to reach approximately £464,000. Antonio, Costa's 27-year-old son who works as a quantity surveyor in Stoke-on-Trent, said: "All of our lives have just been flipped upside down. His sense of smell changed and he kept getting this strange, sweet caramel smell. We didn't think much of it. We definitely didn't know it was a symptom of something so serious." The alteration in Costa's sense of smell remained the only sign anything was wrong. Antonio continued: "It's really bizarre because symptoms-wise, he didn't have much at all. On the odd occasion, he would have a caramel smell, a sweet smell. But it would happen very quickly and once a month or so." "From what we now know they define them as mini seizures; they last seconds; nothing happens to you while you do it." Costa initially suspected he might be dealing with epilepsy, something he had experienced earlier in life. Antonio said that, as a family, they didn't really look into it but advised his dad to get a scan, thinking it was likely linked to his past epilepsy. However, in April, the family faced a horrible truth - Costa was found to have stage 4 brain cancer. Antonio said: "We were shellshocked. We didn't really know how to take it. "We were worried, scared, nervous, but then still trying to get to grips with the situation and what was going on because he had no symptoms. It just kind of proves that you can be a fit and healthy man, yet still have something wrong with you." Antonio continued: "My dad is a fighter. He's always fought all of his life. His nickname has been Rambo all of his life, because he's just known to get through any battle he's had to face. "He was shocked. He was taken aback. He was stunned. He didn't know how to react and I still don't think he knows how to react. The only things the NHS offer, which is the massive problem and why we're doing the fundraising, is a course of radiotherapy and chemotherapy. In the last 20 years the treatments haven't changed for glioblastomas in the UK. "So it's quite a scary thing to be diagnosed with, knowing that there's not much the NHS can do. Put it this way, they're telling us in the consultancy meetings not to cut back on anything and just enjoy your life, in the most harrowing way possible." The family refuses to give up hope. Inspired by success stories, they are exploring alternative therapies abroad, such as DC vaccine therapy in Munich, oncothermia as part of a clinical trial in London, a three-phase immunotherapy programme at the IZOK Clinic in Cologne, and peptide vaccine treatment from a specialist lab in Tübingen. The family needs to raise around £464,000 for these treatments, and have already managed to fundraise more than £260,000. If you want the link to his GoFundMe, follow this link. Costa has recently completed his radiotherapy and chemotherapy courses and has demonstrated an encouraging response, although it remains too early to assess the complete impact of these treatments. Antonio said: "It's harrowing what's going on with treatments for GMBs and the progress they've made over the last 20 years, not just for my dad but for every other patient who is suffering with the same thing. "It's almost like you get this and 'bye-bye', because the diagnosis is a grade four brain tumour glioblastoma, that is unmethylated and it's IDH wild type. Those two things mean it's the worst type of brain cancer you can get. But in reality there is so much that can be offered." Recommended reading: The overwhelming wave of solidarity from their community has profoundly touched the family. Antonio continued: "My dad is a hard-working, typical father figure. Raised three kids, he's got his grandkids. He's loving, he's generous, he'll do anything for anybody. "He's very giving, which is why I think he's reaped the rewards now in terms of people giving back and the GoFundMe. He loves rugby, he used to coach the local football and rugby team when I was growing up. "He's so down to earth, always looking to help people - good morals, good values - but he's a hard worker and he'll fight this just like any battle he has faced before. And he's faced some battles. So this is just going to be another one, it's the toughest test yet."
